United States· US:0078-0937_59dff6dc-c0b0-4f26-9738-32f8a6540033
EGATEN
A medicinal product containing triclabendazole, registered in United States by Novartis Pharmaceuticals Corporation.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- triclabendazole
- Manufacturer
- Novartis Pharmaceuticals Corporation
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 12, 2026
Packs & prices · 1
- ndc1100780937914 TABLET in 1 BLISTER PACK (0078-0937-91)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Triclabendazole in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FranceEGATEN 250 mg, comprimé sécableNOVARTIS PHARMA
- United KingdomEgaten 250mg tabletsImported (Switzerland)
- NorwayEgatenNovartis
Authorised across Europe · EMA
The same active substance is authorised in 1 EEA country. Names it is sold under:
- France · Egaten
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/be464eea-fb0e-489c-8f78-5049dbd44fe6 GET /v1/drugs/be464eea-fb0e-489c-8f78-5049dbd44fe6?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"livertox": {
"summary": null,
"livertox_id": null,
"hepatotoxicity_score": 5
},
"productid": "0078-0937_59dff6dc-c0b0-4f26-9738-32f8a6540033",
"productndc": "0078-0937",
"dosage_form": "TABLET",
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "TRICLABENDAZOLE",
"proprietary_name": "EGATEN",
"active_ingred_unit": "mg/1",
"application_number": "NDA208711",
"marketing_category": "NDA",
"nonproprietary_name": "triclabendazole",
"start_marketing_date": "20190213",
"active_numerator_strength": "250"
}See everything about triclabendazole.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.